期刊文献+

HepG2.2.15细胞系中HBV复制相关抑制因素的变化

Changes of HBV replication-associated inhibitory factors in HepG2.2.15 cells
下载PDF
导出
摘要 目的:研究HBV对其自身复制相关抑制因素的影响,为今后探索提高抗病毒治疗的疗效提供基础。方法:采用实时荧光定量RT-PCR技术检测原蛋白转化酶(PCs)、肝细胞核因子(HNF)3β和转化生长因子(TGF)β1等HBV复制相关抑制因素的mRNA表达,采用Western印迹技术检测部分PCs的蛋白表达,通过比较模型细胞HepG2.2.15和其前体细胞HepG2的表达差别来判断HBV对其自身复制相关抑制因素的影响。结果:HepG2.2.15和HepG2细胞均相对高表达furin和PACE4,但HepG2细胞还高表达PC1/2。与HepG2细胞相比,HepG2.2.15细胞的PC1/3和PC7/8在mRNA水平显著被下调(均P<0.05),且PC1/3在蛋白水平的表达也显著减少。HepG2.2.15细胞的HNF3β和TGFβ1的mRNA表达水平也发生了显著改变,分别增加到5.22倍和降低到0.35倍。结论:HBV的存在对其自身复制相关抑制因素可产生显著影响。下调部分PCs和TGFβ1表达可能有利于HBV自身复制,但上调HNF3β的意义值得深入研究。 Objective To investigate the effects of HBV on its replication-associated inhibitory factors, and to provide information to promote antiviral efficacy in the future. Methods Expressions of proprotein convertases (PCs), hepatoeyte nuclear factor (HNF) 3β, and transforming-growth factor (TGF) β1 mRNA were detected by quantitative real-time RT-PCR technique and protein of some PCs were detected by western blot analysis. The effects of HBV on these replication-associated inhibitory factors were obtained by comparing the difference between HepG2.2.15 cell line and its precursor HepG2 cell line. Results Furin and PACE4 mRNA were highly expressed in both HepG2.2.15 and HepG2 cells, and PC1/3 was highly expressed in HepG2 cells. As compared with those in HepG2 cells, PC1/3 and PC7/8 mRNA were down-regulated in HepG2.2.15 cells (P 〈 0.05), and PC1/3 protein was also down-regulated. HNF313 and TGFβ1 mRNA in HepG2.2.15 cells were up-regulated to 5.22 times and down-regulated to 0.35 times, respectively. Conclusions HBV exerts significant effects on its replication-associated inhibitory factors. The down-regulated expressions of some PCs and TGFβ1 might be favorable for HBV replication, but the importance of the up-regulated expression of HNF3β urges for more studies in the future.
出处 《实用医学杂志》 CAS 北大核心 2011年第11期1914-1917,共4页 The Journal of Practical Medicine
基金 国家自然科学基金项目(编号:30872224) 广东省自然科学基金重点项目(编号:10251008901000018) 广东省科技计划资助项目(编号:2009B030801084)
关键词 肝炎病毒 乙型 原蛋白转化酶 肝细胞核因子3β 转化生长因子β1 Hepatitis B Virus Proprotein convertases Hepatocyte nuclear factor 3β Transforming growth factor β1
  • 相关文献

参考文献10

  • 1Banks K E, Anderson A L, Tang H, et al. Hepatocyte nuclear factor 3 beta inhibits hepatitis B virus replication in vivo [J]. Virol, 2002,76(24) : 12974-12980.
  • 2Chou Y C, Chen M L, Hu C P, et al. Transforming growth factor-beta1 suppresses hepatitis B virus replication primarily through transcriptional inhibition of pregenomic RNA [J]. Hepatology, 2007,46 (3) : 672-681.
  • 3Bertoletti A, Gehring A J. The immune response during hepatitis B virus infection [J]. Gen Virol, 2006,87(Pt 6): 1439-1449.
  • 4Du J, Liang X, Liu Y, et al. Hepatitis B virus core protein inhibits TRAIL-induced apoptosis of hepatocytes by blocking DR5 expression [J]. Cell Death Differ, 2009,16(2) :219-229.
  • 5程杰,时红,雷瑞祥,彭晓谋.乙型肝炎病毒核心蛋白原蛋白转化酶切割假定产物的体外研究[J].中华肝脏病杂志,2010,18(8):595-598. 被引量:1
  • 6Messageot F, Salhi S, Eon P, et al. Proteolytic processing of the hepatitis B virus e antigen precursor. Cleavage at two furin consensus sequences [J]. Biol Chem, 2003,278(2):891-895.
  • 7Lei R X, Shi H, Peng X M, et al. Influence of a single nucleotide polymorphism in the P1 promoter of the furin gene on transcription activity and hepatitis B virus infection [J]. Hepatology, 2009,50 (3) : 763-771.
  • 8雷瑞祥,时红,程杰,朱银洪,彭晓谋.furin基因P1启动子区-229C/T多态性与肝硬化患者肝细胞功能的关系[J].中国病理生理杂志,2010,26(6):1142-1145. 被引量:2
  • 9Liu S, He J, Shih C, et al. Structural comparisons of hepatitis B core antigen particles with different C-terminal lengths [J]. Virus Res, 2010. 149(2) :241-244.
  • 10Raney A K, McLachlan A. Characterization of the hepatitis B virus major surface antigen promoter hepatocyte nuclear factor 3 binding site [J]. Gen Virol, 1997,78(Pt 11):3029-3038.

二级参考文献25

  • 1Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量:1931
  • 2Ganem D,Prince AM.Hepatitis B virus infection-natural history and clinical consequences[J].N Engl J Med,2004 350(11):1118-1129.
  • 3Thursz M.Genetic susceptibility in chronic viral hepatitis[J].Antiviral Res,2001 52(2):113-116.
  • 4Suh Y,Vijg J.SNP discovery in associating genetic variation with human disease phenotypes[J].Mutat Res,2005,573(1-2):41-53.
  • 5Ben-Ari Z,Mor E,Papo O,et al.Cytokine gene polymorphisms in patients infected with hepatitis B virus[J].Am J Gastroenterol,2003,98(1):144-150.
  • 6Messageot F,Salhi S,Eon P,et al.Proteolytic processing of hepatitis B virus e antigen precursor[J].J Bio Chem,2003,278(2):891-895.
  • 7Lei RX,Shi H,Peng XM,et al.Influence of a single nucleotide polymorphism in the P1 promoter of the Furin gene on transcription activity and hepatitis B virus infection[J].Hepatogy,2009,50(3):763-771.
  • 8Misumi Y,Oda K,Fujiwara T,et al.Functional expression of furin demonstrating its intracellular localization and endoprotease activity for processing of proalbumin and complement pro-C3[J].J Biol Chem,1991,266(25):16954-16959.
  • 9Wallin R,Stanton C,Hutson SM.Intracellular maturation of the gamma-carboxyglutamic acid (Gla) region in prothrombin coincides with release of the propeptide[J].Biochem J,1993,291 (Pt 3):723-727.
  • 10Peng XM,Gu L,Huang YS,et al.Simultaneous detection of two major lamivudine-resistant mutants using competitively differentiated-PCR[J].J Virol Methods,2005,128(1-2):168-175.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部